相关实验视频
Updated: Sep 15, 2025

07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.5K
表观基因组调节剂和甲状腺激素受体β激动剂:甲状腺癌瘤抑制的新范式
John L Rustad1, Noelle E Gillis2, James Lignos1,3
1University of Vermont Cancer Center, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA.
Endocrinology
|July 14, 2025
概括
甲状腺激素受体β (TRβ) 在甲状腺癌中起到瘤抑制作用. 针对TRβ相互作用者与表观遗传抑制剂可能为侵袭性甲状腺癌提供新的治疗方法.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 内分泌学 在内分泌学.
背景情况:
- 甲状腺激素受体β (TRβ) 是一种参与调节基因表达的瘤抑制剂.
- 侵袭性甲状腺癌表现出异常的表观基因信号,染色质可访问性和基因表达.
- 缺乏针对晚期和耐药甲状腺癌的有效治疗方法.
研究的目的:
- 审查关于甲状腺恶性瘤中TRβ表观基因组景观的新发现.
- 为了识别TRβ相互作用体,并绘制功能蛋白群落的地图.
- 探索针对TRβ相互作用体治疗甲状腺癌治疗的治疗策略.
主要方法:
- 关于甲状腺癌中TRβ信号传递的最新研究的综述.
- 鉴定TRβ相互作用体及其功能性蛋白质群落.
- 探索涉及TRβ激动剂和表观遗传酶抑制剂的组合疗法.
主要成果:
- 在甲状腺细胞中发现了新的TRβ相互作用体.
- 在TRβ相互作用体内绘制了九个不同的功能性蛋白质群落.
- 研究了针对TRβ相互作用体与表观遗传抑制剂和TRβ激动剂的协同效应.
结论:
- 了解TRβ的表观基因组作用对于阻止甲状腺瘤进展至关重要.
- 准TRβ相互作用体为甲状腺癌提供了潜在的新疗法途径.
- 用表观遗传抑制剂和TRβ激动剂进行组合治疗可能会重编程瘤表观遗传学并抑制瘤性程序.
相关概念视频
Synthesis and Regulation of Thyroid Hormones
5.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.1K
Mitogens and the Cell Cycle
6.9K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Transducer Mechanism: Nuclear Receptors
1.7K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.7K
Functions of Thyroid Hormones
3.2K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
3.2K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.1K

